20186546

Source:http://linkedlifedata.com/resource/pubmed/id/20186546

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0072348, umls-concept:C0205210, umls-concept:C0449438, umls-concept:C0702240, umls-concept:C0948089, umls-concept:C1373125, umls-concept:C1418370, umls-concept:C1514496, umls-concept:C1521970, umls-concept:C1524063, umls-concept:C1705930, umls-concept:C2347515
pubmed:issue	6
pubmed:dateCreated	2010-5-26
pubmed:abstractText	The most recent ESC guidelines for percutaneous coronary intervention (PCI) recommend the use of glycoprotein IIb/IIIa inhibitors (GPI) in high risk patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS), particularly in diabetics. Little is known about the adherence to these guidelines within Europe.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/20186546-10562258, http://linkedlifedata.com/resource/pubmed/commentcorrection/20186546-10676673, http://linkedlifedata.com/resource/pubmed/commentcorrection/20186546-10961966, http://linkedlifedata.com/resource/pubmed/commentcorrection/20186546-11733392, http://linkedlifedata.com/resource/pubmed/commentcorrection/20186546-12208224, http://linkedlifedata.com/resource/pubmed/commentcorrection/20186546-12628712, http://linkedlifedata.com/resource/pubmed/commentcorrection/20186546-14724302, http://linkedlifedata.com/resource/pubmed/commentcorrection/20186546-15523070, http://linkedlifedata.com/resource/pubmed/commentcorrection/20186546-15531766, http://linkedlifedata.com/resource/pubmed/commentcorrection/20186546-15769784, http://linkedlifedata.com/resource/pubmed/commentcorrection/20186546-15802360, http://linkedlifedata.com/resource/pubmed/commentcorrection/20186546-15894970, http://linkedlifedata.com/resource/pubmed/commentcorrection/20186546-16533938, http://linkedlifedata.com/resource/pubmed/commentcorrection/20186546-16781361, http://linkedlifedata.com/resource/pubmed/commentcorrection/20186546-17124018, http://linkedlifedata.com/resource/pubmed/commentcorrection/20186546-17146606, http://linkedlifedata.com/resource/pubmed/commentcorrection/20186546-17569677, http://linkedlifedata.com/resource/pubmed/commentcorrection/20186546-17575335, http://linkedlifedata.com/resource/pubmed/commentcorrection/20186546-18046527, http://linkedlifedata.com/resource/pubmed/commentcorrection/20186546-18757948, http://linkedlifedata.com/resource/pubmed/commentcorrection/20186546-19332455, http://linkedlifedata.com/resource/pubmed/commentcorrection/20186546-19378677, http://linkedlifedata.com/resource/pubmed/commentcorrection/20186546-7739710, http://linkedlifedata.com/resource/pubmed/commentcorrection/20186546-8450161, http://linkedlifedata.com/resource/pubmed/commentcorrection/20186546-9036746, http://linkedlifedata.com/resource/pubmed/commentcorrection/20186546-9182212
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101264123
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Platelet Aggregation Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Platelet Glycoprotein GPIIb-IIIa...
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	1861-0692
pubmed:author	pubmed-author:BauerTimmT, pubmed-author:EberliFranzF, pubmed-author:GittAnselm KAK, pubmed-author:HammChristian WCW, pubmed-author:HochadelMatthiasM, pubmed-author:MöllmannHelgeH, pubmed-author:MarcoJeanJ, pubmed-author:NefHolger MHM, pubmed-author:Seabra-GomesRicardoR, pubmed-author:SerruysPatrickP, pubmed-author:SilberSigmundS, pubmed-author:VahanianAlecA, pubmed-author:WeidingerFranzF, pubmed-author:WijnsWilliamW, pubmed-author:ZeymerUweU
pubmed:issnType	Electronic
pubmed:volume	99
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	375-83
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:20186546-Acute Coronary Syndrome, pubmed-meshheading:20186546-Aged, pubmed-meshheading:20186546-Angioplasty, Balloon, Coronary, pubmed-meshheading:20186546-Diabetes Mellitus, pubmed-meshheading:20186546-Diabetic Angiopathies, pubmed-meshheading:20186546-Female, pubmed-meshheading:20186546-Guideline Adherence, pubmed-meshheading:20186546-Humans, pubmed-meshheading:20186546-Male, pubmed-meshheading:20186546-Middle Aged, pubmed-meshheading:20186546-Platelet Aggregation Inhibitors, pubmed-meshheading:20186546-Platelet Glycoprotein GPIIb-IIIa Complex, pubmed-meshheading:20186546-Practice Guidelines as Topic, pubmed-meshheading:20186546-Risk Factors, pubmed-meshheading:20186546-Treatment Outcome
pubmed:year	2010
pubmed:articleTitle	Use of platelet glycoprotein IIb/IIIa inhibitors in diabetics undergoing PCI for non-ST-segment elevation acute coronary syndromes: impact of clinical status and procedural characteristics.
pubmed:affiliation	Kerckhoff-Klinik, Kardiologie, Benekestr. 2-8, 61231, Bad Nauheim, Germany. Bauer-Timm@gmx.de
pubmed:publicationType	Journal Article